Jim Cramer Recently Talked About These 15 Stocks

9. LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Number of Hedge Fund Holders: 20

LeMaitre Vascular, Inc. (NASDAQ:LMAT) was mentioned during the episode, and here’s what Cramer had to say:

“Now I like the medical device market right now, and I think this LMAT, LeMaitre looks like a really good under-the-radar way to play it.”

LeMaitre Vascular (NASDAQ:LMAT) develops and manufactures medical devices and implants for vascular surgery. The company provides a wide range of products like grafts, catheters, biologic patches, and vascular grafts. As per the company’s projections, organic sales are expected to increase by 10% in 2025. In the same period, the gross margin is expected to reach 69.7%.

The company has attributed it to benefits stemming from price adjustments implemented in January 2025 and improved efficiency in its manufacturing processes. LeMaitre Vascular’s (NASDAQ:LMAT) operating income for the full year is expected to be $59.8 million, which is a 15% increase. Additionally, EPS is forecasted to rise by 16% to $2.24.